A L Gould

发表

Re-evaluating design specifications of longitudinal clinical trials without unblinding when the key response is rate of change.

W J Shih, A L Gould, 1995, Statistics in medicine.

Sample size re‐estimation: recent developments and practical considerations

A L Gould, A. Gould, 2001, Statistics in medicine.

Interim analyses for monitoring clinical trials that do not materially affect the type I error rate.

A L Gould, A. Gould, A. Lawrence Gould, 1992, Statistics in medicine.

Modifying the design of ongoing trials without unblinding.

W J Shih, A L Gould, A. Gould, 1998, Statistics in medicine.

A new approach to the analysis of clinical drug trials with withdrawals.

A L Gould, A. Gould, 1980, Biometrics.

Discussion of individual bioequivalence by M.-L. Chen.

A L Gould, 1997, Journal of biopharmaceutical statistics.

Sample sizes for event rate equivalence trials using prior information.

A L Gould, A. Gould, 1993, Statistics in medicine.

Another view of active-controlled trials.

A L Gould, A. Gould, 1991, Controlled clinical trials.

An Evaluation of Computer‐Aided Disproportionality Analysis for Post‐Marketing Signal Detection

A L Gould, B E Wiholm, A. Gould, 2007, Clinical pharmacology and therapeutics.

Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: meta-analysis of randomized clinical trials.

A L Gould, P. Boyle, C. Roehrborn, 1996, Urology.